BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10516)

  • 1. [Experiences with isosorbide dinitrate in combination with a beta receptor blockader (Bupranolol)].
    Bernat AC; Riera de Barcia L
    Med Monatsschr; 1976 Oct; 30(10):470-3. PubMed ID: 10516
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of coronary insufficiency. Comparative study on the effect of a nitro compound (isosorbidedinitrate), a beta sympatholytic (bupranolol) and a drug combination (oxycardin)].
    Philipp R; Kutscha W
    Med Welt; 1980 May; 31(21):817-20. PubMed ID: 7392937
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical experiences with the Kö 1366 (Bunitrololhydrochloride) beta receptor blockader and the combination Kö 1366/Isosorbitdinitrate in patients with coronary disease].
    Holzhey P
    Wien Med Wochenschr; 1975 Oct; 125(42-44):624-9. PubMed ID: 5819
    [No Abstract]   [Full Text] [Related]  

  • 4. [Isosorbide dinitrate and bupranolol in the therapy of coronary heart disease (author's transl)].
    Pascal N; Eggert R
    Arzneimittelforschung; 1978; 28(5):847-50. PubMed ID: 373775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Patient compliance with a free and fixed combination of isosorbide dinitrate and bupranolol].
    Gill E; Bechler M; Forst HT
    ZFA (Stuttgart); 1980 May; 56(14):1037-44. PubMed ID: 7415470
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of ischemic heart disease with beta-receptor blockers and isosorbide dinitrate (author's transl)].
    Wermuth G
    MMW Munch Med Wochenschr; 1975 Oct; 117(40):1613-4. PubMed ID: 241932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The immediate effect of beta-isoket on the internal ocular pressure in patients with chronic simple glaucoma (author's transl)].
    Oancea I
    Klin Monbl Augenheilkd; 1975 Oct; 167(4):618-22. PubMed ID: 1574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of isosorbide-5-mononitrate, metipranolol and a combination of the two in experimental myocardial ischemia in the awake dog].
    Sponer G; Voss E; Dietmann K
    Med Welt; 1981 Apr; 32(14A):492-6. PubMed ID: 6113532
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of nifedipine and isosorbide dinitrate in angina pectoris with particular reference to arterial oxygen saturation.
    Tirlapur VG; Mir MA
    Postgrad Med J; 1983; 59 Suppl 2():30-4. PubMed ID: 6136959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of angina pectoris with beta-receptor blockaders a slow-releasing isosorbide dinitrate preparation].
    Kappenberger L; Fellmann H; Nager F
    Schweiz Med Wochenschr; 1973 Dec; 103(50):1789-92. PubMed ID: 4149035
    [No Abstract]   [Full Text] [Related]  

  • 11. [Adrenergic beta receptor blockaders and nitrites in the treatment of angina pectoris].
    Haarmann K; Neff K
    Schweiz Rundsch Med Prax; 1974 Mar; 63(12):355-9. PubMed ID: 4150716
    [No Abstract]   [Full Text] [Related]  

  • 12. [Long-term testing of a coronary therapeutic agent under general practice conditions].
    Pascal N
    Med Welt; 1978 Apr; 29(15):635-40. PubMed ID: 417229
    [No Abstract]   [Full Text] [Related]  

  • 13. [Coronary therapeutic effectiveness of low-dose IS-5-MN in comparison with the combination IS-5-MH and metipranolol and placebo].
    Müller G; Uberbacher HJ; Glocke M
    Med Welt; 1983 Mar; 34(10):321-7. PubMed ID: 6133205
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative ergometric tests in coronary disease patients under betasympathicolysis using Betadrenol and Isoket].
    Raff U; Jeschke D
    Med Welt; 1977 Sep; 28(38):1518-21. PubMed ID: 20547
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of coronary heart disease. Oxycardin retard in simultaneously existing arterial hypertension].
    Hoffmann J
    Fortschr Med; 1983 Apr; 101(16):764-7. PubMed ID: 6852752
    [No Abstract]   [Full Text] [Related]  

  • 16. [Molsidomin compared to nitrates. Use in patients with manifest coronary disease].
    Lehmann HU; Brix W; Hochrein H
    MMW Munch Med Wochenschr; 1979 Sep; 121(36):1149-51. PubMed ID: 40120
    [No Abstract]   [Full Text] [Related]  

  • 17. [Ergometric study of the association of a beta-blocker and a nitrate derivative].
    Jullien G
    Nouv Presse Med; 1978 Sep; 7(31):2727-31. PubMed ID: 30951
    [No Abstract]   [Full Text] [Related]  

  • 18. [ECG clinical trial with an antianginal drug (author's transl)].
    Fernandez Garcia JJ; Sánchez de la Cuesta y Alarcón F; Tallón-Cantero R; Martínez Rangel F; Bermudo Fernández L; Tallón Moreno R; Garrigo Toro A; de Lis Morales J
    Folia Clin Int (Barc); 1976 Jan; 26(1):49-55. PubMed ID: 976530
    [No Abstract]   [Full Text] [Related]  

  • 19. [1st experiences with the clinical use of a new beta-blocking agent (tolamolol) in some heart diseases].
    Neviani V; Tosi P; Prampolini ML
    Clin Ter; 1976 Jun; 77(5):451-8. PubMed ID: 12901
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic experiences with viskenit (LBI-45) in ischemic heart disease and symptoms of angina pectoris].
    Ripka O; Chvatíková J
    Med Monatsschr; 1977 Jun; 31(6):281-3. PubMed ID: 20565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.